Transforming growth factor beta and cyclosporin A inhibit the inducible activity of the interleukin-2 gene in T cells through a noncanonical octamer-binding site - PubMed (original) (raw)

Transforming growth factor beta and cyclosporin A inhibit the inducible activity of the interleukin-2 gene in T cells through a noncanonical octamer-binding site

T Brabletz et al. Mol Cell Biol. 1993 Feb.

Abstract

Transforming growth factor beta (TGF-beta) has a growth-inhibitory effect on numerous different cell types of the immune system, including T lymphocytes. We show in this study that the inhibitory action of TGF-beta on T lymphocytes is accompanied by a block of interleukin 2 (IL-2) gene expression which is mediated, at least in part, by inhibition of IL-2 promoter/enhancer activity. The functional analysis of cis-regulatory (proto-enhancer) elements of the IL-2 enhancer/promoter region showed that the most TGF-beta-responsive element maps to its so-called upstream promoter site. The proto-enhancer activity of the upstream promoter site element is also inhibited by cyclosporin A. The upstream promoter site DNA harbors two noncanonical, closely linked binding sequences for octamer and AP-1-like factors. Both sites are involved in the establishment of IL-2 enhancer activity. Since the activity of genuine octamer sites but not that of AP-1-binding sites is also impaired by TGF-beta and cyclosporin A in El4 T lymphoma cells, we conclude that both immunosuppressives interfere with the activity but not the DNA binding of octamer factors in T lymphocytes.

PubMed Disclaimer

Similar articles

• Multiple closely-linked NFAT/octamer and HMG I(Y) binding sites are part of the interleukin-4 promoter.
  Chuvpilo S, Schomberg C, Gerwig R, Heinfling A, Reeves R, Grummt F, Serfling E. Chuvpilo S, et al. Nucleic Acids Res. 1993 Dec 11;21(24):5694-704. doi: 10.1093/nar/21.24.5694. Nucleic Acids Res. 1993. PMID: 8284217 Free PMC article.
• Interleukin-2 transcription is regulated in vivo at the level of coordinated binding of both constitutive and regulated factors.
  Garrity PA, Chen D, Rothenberg EV, Wold BJ. Garrity PA, et al. Mol Cell Biol. 1994 Mar;14(3):2159-69. doi: 10.1128/mcb.14.3.2159-2169.1994. Mol Cell Biol. 1994. PMID: 8114746 Free PMC article.
• Positive and negative regulation of IL-2 gene expression: role of multiple regulatory sites.
  Zhang L, Nabel GJ. Zhang L, et al. Cytokine. 1994 May;6(3):221-8. doi: 10.1016/1043-4666(94)90016-7. Cytokine. 1994. PMID: 8054477
• Positive and negative regulation of the composite octamer motif of the interleukin 2 enhancer by AP-1, Oct-2, and retinoic acid receptor.
  de Grazia U, Felli MP, Vacca A, Farina AR, Maroder M, Cappabianca L, Meco D, Farina M, Screpanti I, Frati L, Gulino A. de Grazia U, et al. J Exp Med. 1994 Oct 1;180(4):1485-97. doi: 10.1084/jem.180.4.1485. J Exp Med. 1994. PMID: 7931079 Free PMC article.
• Octamer factors exert a dual effect on the IL-2 and IL-4 promoters.
  Pfeuffer I, Klein-Hessling S, Heinfling A, Chuvpilo S, Escher C, Brabletz T, Hentsch B, Schwarzenbach H, Matthias P, Serfling E. Pfeuffer I, et al. J Immunol. 1994 Dec 15;153(12):5572-85. J Immunol. 1994. PMID: 7989759

Cited by

• Turning cold tumors into hot tumors by improving T-cell infiltration.
  Liu YT, Sun ZJ. Liu YT, et al. Theranostics. 2021 Mar 11;11(11):5365-5386. doi: 10.7150/thno.58390. eCollection 2021. Theranostics. 2021. PMID: 33859752 Free PMC article. Review.
• 'Yin-Yang' functions of transforming growth factor-beta and T regulatory cells in immune regulation.
  Wan YY, Flavell RA. Wan YY, et al. Immunol Rev. 2007 Dec;220:199-213. doi: 10.1111/j.1600-065X.2007.00565.x. Immunol Rev. 2007. PMID: 17979848 Free PMC article. Review.
• Intratumoral immunotherapy with mRNAs encoding chimeric protein constructs encompassing IL-12, CD137 agonists, and TGF-β antagonists.
  Cirella A, Bolaños E, Luri-Rey C, Di Trani CA, Olivera I, Gomis G, Glez-Vaz J, Pinci B, Garasa S, Sánchez-Gregorio S, Azpilikueta A, Eguren-Santamaria I, Valencia K, Palencia B, Alvarez M, Ochoa MC, Teijeira Á, Berraondo P, Melero I. Cirella A, et al. Mol Ther Nucleic Acids. 2023 Jul 28;33:668-682. doi: 10.1016/j.omtn.2023.07.026. eCollection 2023 Sep 12. Mol Ther Nucleic Acids. 2023. PMID: 37650116 Free PMC article.
• TGF-β inhibits IL-7-induced proliferation in memory but not naive human CD4+ T cells.
  Nguyen TP, Sieg SF. Nguyen TP, et al. J Leukoc Biol. 2017 Aug;102(2):499-506. doi: 10.1189/jlb.3A1216-520RR. Epub 2017 Jun 6. J Leukoc Biol. 2017. PMID: 28588029 Free PMC article.
• Identification of cis-acting regulatory elements controlling interleukin-4 gene expression in T cells: roles for NF-Y and NF-ATc.
  Szabo SJ, Gold JS, Murphy TL, Murphy KM. Szabo SJ, et al. Mol Cell Biol. 1993 Aug;13(8):4793-805. doi: 10.1128/mcb.13.8.4793-4805.1993. Mol Cell Biol. 1993. PMID: 8336717 Free PMC article.

References

1. 1. Science. 1989 Dec 22;246(4937):1617-20 - PubMed
2. 1. Nature. 1988 Mar 10;332(6160):166-71 - PubMed
3. 1. Mol Cell Biol. 1990 Apr;10(4):1492-7 - PubMed
4. 1. Cell. 1990 Apr 20;61(2):267-78 - PubMed
5. 1. Proc Natl Acad Sci U S A. 1990 May;87(10):3758-62 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central
  • Taylor & Francis

• Other Literature Sources

  • The Lens - Patent Citations Database